These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 9466020

  • 21. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J.
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [Abstract] [Full Text] [Related]

  • 22. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR.
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [Abstract] [Full Text] [Related]

  • 23. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 24. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
    Boer C, Meesters MI, Veerhoek D, Vonk ABA.
    Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
    [Abstract] [Full Text] [Related]

  • 25. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
    Kunz SA, Miles LF, Ianno DJ, Mirowska-Allen KL, Matalanis G, Bellomo R, Seevanayagam S.
    Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
    [Abstract] [Full Text] [Related]

  • 26. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management.
    Hoenicka M, Rupp P, Müller-Eising K, Deininger S, Kunert A, Liebold A, Gorki H.
    J Thromb Haemost; 2015 Jul; 13(7):1196-206. PubMed ID: 25954849
    [Abstract] [Full Text] [Related]

  • 27. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 28. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L, Borowiec JW, Thelin S, Hultman J.
    Scand Cardiovasc J; 1997 Mar; 31(5):275-81. PubMed ID: 9406294
    [Abstract] [Full Text] [Related]

  • 29. Clinical effects of different protamine doses after cardiopulmonary bypass.
    Svenarud P, Øvrum E.
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):119-23. PubMed ID: 12079933
    [Abstract] [Full Text] [Related]

  • 30. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD, Wall MH, Gillies BS, Fitch JC, Soltow LO, Chandler WL.
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [Abstract] [Full Text] [Related]

  • 31. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 32. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L, Borowiec JW, Thelin S, Hultman J.
    Scand Cardiovasc J; 1997 Aug; 31(6):275-81. PubMed ID: 9498931
    [Abstract] [Full Text] [Related]

  • 33. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 34. Accurate protamine:heparin matching (not just smaller protamine doses) decreases postoperative bleeding in cardiac surgery; results from a high-volume academic medical center.
    Vespe MW, Stone ME, Lin HM, Ouyang Y.
    Perfusion; 2024 Oct; 39(7):1335-1347. PubMed ID: 37493300
    [Abstract] [Full Text] [Related]

  • 35. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P, te Velthuis H, Eerenberg-Belmer AJ, Yazdanbakhsh AP, de Beaumont EM, Eijsman L, Trouwborst A, Hack CE.
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation; A prospective randomized study.
    Gkiouliava A, Argiriadou H, Antonitsis P, Goulas A, Papapostolou E, Sarridou D, Karapanagiotidis GT, Anastasiadis K.
    Perfusion; 2024 Nov; 39(8):1595-1604. PubMed ID: 37776194
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.